A Review on Platelet Activating Factor Inhibitors: Could a New Class of Potent Metal-Based Anti-Inflammatory Drugs Induce Anticancer Properties?

In this minireview, we refer to recent results as far as the Platelet Activating Factor (PAF) inhibitors are concerned. At first, results of organic compounds (natural and synthetic ones and specific and nonspecific) as inhibitors of PAF are reported. Emphasis is given on recent results about a new...

Full description

Saved in:
Bibliographic Details
Main Authors: Vasiliki D. Papakonstantinou, Nefeli Lagopati, Effie C. Tsilibary, Constantinos A. Demopoulos, Athanassios I. Philippopoulos
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Bioinorganic Chemistry and Applications
Online Access:http://dx.doi.org/10.1155/2017/6947034
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558487906811904
author Vasiliki D. Papakonstantinou
Nefeli Lagopati
Effie C. Tsilibary
Constantinos A. Demopoulos
Athanassios I. Philippopoulos
author_facet Vasiliki D. Papakonstantinou
Nefeli Lagopati
Effie C. Tsilibary
Constantinos A. Demopoulos
Athanassios I. Philippopoulos
author_sort Vasiliki D. Papakonstantinou
collection DOAJ
description In this minireview, we refer to recent results as far as the Platelet Activating Factor (PAF) inhibitors are concerned. At first, results of organic compounds (natural and synthetic ones and specific and nonspecific) as inhibitors of PAF are reported. Emphasis is given on recent results about a new class of the so-called metal-based inhibitors of PAF. A small library of 30 metal complexes has been thus created; their anti-inflammatory activity has been further evaluated owing to their inhibitory effect against PAF in washed rabbit platelets (WRPs). In addition, emphasis has also been placed on the identification of preliminary structure-activity relationships for the different classes of metal-based inhibitors.
format Article
id doaj-art-e7716db236a741da8fe236441704ffcf
institution Kabale University
issn 1565-3633
1687-479X
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Bioinorganic Chemistry and Applications
spelling doaj-art-e7716db236a741da8fe236441704ffcf2025-02-03T01:32:15ZengWileyBioinorganic Chemistry and Applications1565-36331687-479X2017-01-01201710.1155/2017/69470346947034A Review on Platelet Activating Factor Inhibitors: Could a New Class of Potent Metal-Based Anti-Inflammatory Drugs Induce Anticancer Properties?Vasiliki D. Papakonstantinou0Nefeli Lagopati1Effie C. Tsilibary2Constantinos A. Demopoulos3Athanassios I. Philippopoulos4Laboratory of Biochemistry, Faculty of Chemistry, National and Kapodistrian University of Athens, 15771 Athens, GreeceInstitute of Biosciences & Applications, NCSR Demokritos, 15310 Agia Paraskevi, GreeceInstitute of Biosciences & Applications, NCSR Demokritos, 15310 Agia Paraskevi, GreeceLaboratory of Biochemistry, Faculty of Chemistry, National and Kapodistrian University of Athens, 15771 Athens, GreeceLaboratory of Inorganic Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, GreeceIn this minireview, we refer to recent results as far as the Platelet Activating Factor (PAF) inhibitors are concerned. At first, results of organic compounds (natural and synthetic ones and specific and nonspecific) as inhibitors of PAF are reported. Emphasis is given on recent results about a new class of the so-called metal-based inhibitors of PAF. A small library of 30 metal complexes has been thus created; their anti-inflammatory activity has been further evaluated owing to their inhibitory effect against PAF in washed rabbit platelets (WRPs). In addition, emphasis has also been placed on the identification of preliminary structure-activity relationships for the different classes of metal-based inhibitors.http://dx.doi.org/10.1155/2017/6947034
spellingShingle Vasiliki D. Papakonstantinou
Nefeli Lagopati
Effie C. Tsilibary
Constantinos A. Demopoulos
Athanassios I. Philippopoulos
A Review on Platelet Activating Factor Inhibitors: Could a New Class of Potent Metal-Based Anti-Inflammatory Drugs Induce Anticancer Properties?
Bioinorganic Chemistry and Applications
title A Review on Platelet Activating Factor Inhibitors: Could a New Class of Potent Metal-Based Anti-Inflammatory Drugs Induce Anticancer Properties?
title_full A Review on Platelet Activating Factor Inhibitors: Could a New Class of Potent Metal-Based Anti-Inflammatory Drugs Induce Anticancer Properties?
title_fullStr A Review on Platelet Activating Factor Inhibitors: Could a New Class of Potent Metal-Based Anti-Inflammatory Drugs Induce Anticancer Properties?
title_full_unstemmed A Review on Platelet Activating Factor Inhibitors: Could a New Class of Potent Metal-Based Anti-Inflammatory Drugs Induce Anticancer Properties?
title_short A Review on Platelet Activating Factor Inhibitors: Could a New Class of Potent Metal-Based Anti-Inflammatory Drugs Induce Anticancer Properties?
title_sort review on platelet activating factor inhibitors could a new class of potent metal based anti inflammatory drugs induce anticancer properties
url http://dx.doi.org/10.1155/2017/6947034
work_keys_str_mv AT vasilikidpapakonstantinou areviewonplateletactivatingfactorinhibitorscouldanewclassofpotentmetalbasedantiinflammatorydrugsinduceanticancerproperties
AT nefelilagopati areviewonplateletactivatingfactorinhibitorscouldanewclassofpotentmetalbasedantiinflammatorydrugsinduceanticancerproperties
AT effiectsilibary areviewonplateletactivatingfactorinhibitorscouldanewclassofpotentmetalbasedantiinflammatorydrugsinduceanticancerproperties
AT constantinosademopoulos areviewonplateletactivatingfactorinhibitorscouldanewclassofpotentmetalbasedantiinflammatorydrugsinduceanticancerproperties
AT athanassiosiphilippopoulos areviewonplateletactivatingfactorinhibitorscouldanewclassofpotentmetalbasedantiinflammatorydrugsinduceanticancerproperties
AT vasilikidpapakonstantinou reviewonplateletactivatingfactorinhibitorscouldanewclassofpotentmetalbasedantiinflammatorydrugsinduceanticancerproperties
AT nefelilagopati reviewonplateletactivatingfactorinhibitorscouldanewclassofpotentmetalbasedantiinflammatorydrugsinduceanticancerproperties
AT effiectsilibary reviewonplateletactivatingfactorinhibitorscouldanewclassofpotentmetalbasedantiinflammatorydrugsinduceanticancerproperties
AT constantinosademopoulos reviewonplateletactivatingfactorinhibitorscouldanewclassofpotentmetalbasedantiinflammatorydrugsinduceanticancerproperties
AT athanassiosiphilippopoulos reviewonplateletactivatingfactorinhibitorscouldanewclassofpotentmetalbasedantiinflammatorydrugsinduceanticancerproperties